Check out your Company Bowl for anonymous work chats.
3,000+ GLP-1 patients just told us what’s working, what’s breaking, and what they wish their employers understood. Explore one of the largest GLP-1 patient surveys of its kind and see the must-know insights for your population strategy. https://lnkd.in/dpNQNvYQ
3,000+ GLP-1 patients just told us what's working, what's breaking, and what they wish their employers understood. Explore one of the largest GLP-1 patient surveys of its kind and see the must-know... | Omada Health
You read that right. In our latest 12-week comparative study on body composition and GLP-1s, the group who received Omada’s support reported greater improvements in lifestyle change, physical function, and confidence in their ability to lose weight. Want to see what else our study uncovered? Read the full white paper now. https://lnkd.in/dUUrZQq9
You read that right. In our latest 12-week comparative study on body composition and GLP-1s, the group who received Omada's support reported greater improvements in lifestyle change, physical... | Omada Health
Join Horizon Day 2026 for a LinkedIn Live reveal of how Omada is redefining cardiometabolic care as GLP-1s reshape the obesity treatment landscape. As new medication options rapidly transform how we approach obesity—and concerns around access, cost, and fragmentation rise just as quickly—it’s never been more important to connect the dots across the care continuum. Be among the first to see how our latest advancements—GLP-1 prescribing capabilities, GLP-1 Flex Care benefit design, and targeted cholesterol support—come together to connect those dots, delivering continuous, whole-person cardiometabolic care. You’ll walk away with a clear view of what this means for benefit strategies, clinical outcomes, and the member experience. Don't miss Omada's Sean Duffy and Wei-Li Shao as they showcase Omada’s integrated approach, including a walk-through of GLP-1 prescribing and the guided medication care experience. They'll also reveal the strategy and vision shaping the future of Omada's care model. We’ll be taking audience Q&A in real time during the event, so join us—and join the conversation.
Join Horizon Day 2026 for a LinkedIn Live reveal of how Omada is redefining cardiometabolic care as GLP-1s reshape the obesity treatment landscape. As new medication options rapidly transform how we... | Omada Health | 167 comments
Omada Health is proud to be Certified™ by Great Place To Work® for the 3rd year in a row. The prestigious award is based entirely on what current employees say about their experience working at Omada. This year, 86% of employees said it’s a great place To Work – 29% higher than the average U.S. company. Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. Read more about our award here: https://www.greatplacetowork.com/certified-company/7022924
Omada Health is proud to be Certified™ by Great Place To Work® for the 3rd year in a row. The prestigious award is based entirely on what current employees say about their experience working at Omada. This year, 86% of employees said it’s a great place To Work – 29% higher than the average U.S. company. Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. Read more about our award here: https://www.greatplacetowork.com/certified-company/7022924
Members don’t feel accountable to a prescription or an app; they feel accountable to people. That’s why Omada’s care model is, and will remain, human‑led. We use AI to help our care teams scale tailored support, so members get guidance between visits - not just at them. Our research shows Omada’s GLP-1 care track is associated with better outcomes than what is typically seen in real world evidence without structured lifestyle support. Learn more about how our GLP-1 offerings meet members where they’re at for care at scale: https://lnkd.in/dk8DSZR5
Members don't feel accountable to a prescription or an app; they feel accountable to people. That's why Omada's care model is, and will remain, human‑led. We use AI to help our care teams scale... | Omada Health
Are GLP-1s changing women’s health? In our latest Proof Points for hashtag#WomensHealthMonth, Crystal Onwu, PharmD, RPh explores the evolution of women’s cardiometabolic risk over time, and how GLP-1s might be changing the trajectory. Read this article to learn: → The role of body composition vs. BMI vs. body shape → How cardiometabolic health changes over a woman’s lifespan → Why maintaining muscle mass is key to reducing disease risk Check it out here 👇
Women's Health in the GLP-1 Era: Are We Better At Losing Weight Now? | Omada Health
High cholesterol rarely shows up alone. It often occurs alongside obesity, hypertension, and diabetes—quietly stacking cardiovascular risk over years. By adding Omada for Cholesterol to our integrated platform, we’re addressing high cholesterol as part of the same cardiometabolic system as weight, blood pressure, and diabetes. Members get between‑visit support that helps implement daily lifestyle changes to actively manage high cholesterol alongside other risks. Learn more: https://lnkd.in/dxV4X4M3
High cholesterol rarely shows up alone. It often occurs alongside obesity, hypertension, and diabetes-quietly stacking cardiovascular risk over years. By adding Omada for Cholesterol to our... | Omada Health
😵💫 The GLP-1 market is getting more complex for employers and members alike with multiple injectables, multiple orals, fragmented access, and rapidly shifting benefit designs. Employers don’t need another point solution; they need help navigating. Omada meets that need with a spectrum of GLP‑1 services—companion lifestyle care, prescribing, and flexible benefit pathways, so organizations can provide support and meet their members where they’re at, without rebuilding their strategy every quarter. Learn more: https://lnkd.in/dk8DSZR5
😵💫 The GLP-1 market is getting more complex for employers and members alike with multiple injectables, multiple orals, fragmented access, and rapidly shifting benefit designs. Employers don't... | Omada Health
In trial data, nearly 40% of weight loss from GLP-1 patients came from lean mass. That’s almost half! Why should individuals and organizations care? Our latest whitepaper breaks down how loss of lean mass can undermine long-term GLP-1 weight loss outcomes. Read it now. https://lnkd.in/g7huaUes
GLP-1 Weight Loss Outcomes and Lean Mass | Omada Health posted on the topic | LinkedIn
In this member + coach spotlight, see how Omada’s health coaches help people take real‑life obstacles and turn them into small, confident steps—checking blood pressure, taking a short walk, choosing a nutritious meal—that add up over time for better health. We call this compassionate intelligence: human care teams supported by AI, working together to help deliver tangible outcomes across key metrics. Learn more: https://lnkd.in/d6qDdGwb
In this member + coach spotlight, see how Omada's health coaches help people take real‑life obstacles and turn them into small, confident steps-checking blood pressure, taking a short walk, choosing... | Omada Health